GURUFOCUS.COM » STOCK LIST » Technology » Software » NCI Inc (NAS:NCIT) » Definitions » Cash Flow from Financing

NCI (NCIT) Cash Flow from Financing : $-9.6 Mil (TTM As of Jun. 2017)


View and export this data going back to 2005. Start your Free Trial

What is NCI Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Jun. 2017, NCI paid $0.0 Mil more to buy back shares than it received from issuing new shares. It spent $2.0 Mil paying down its debt. It paid $0.0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.0 Mil from paying cash dividends to shareholders. It received $0.4 Mil on other financial activities. In all, NCI spent $1.6 Mil on financial activities for the three months ended in Jun. 2017.


NCI Cash Flow from Financing Historical Data

The historical data trend for NCI's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NCI Cash Flow from Financing Chart

NCI Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -41.81 -16.71 -0.42 9.30 -12.58

NCI Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.39 -6.89 -0.95 -0.16 -1.56

NCI Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

NCI's Cash from Financing for the fiscal year that ended in Dec. 2016 is calculated as:

NCI's Cash from Financing for the quarter that ended in Jun. 2017 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NCI  (NAS:NCIT) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

NCI's issuance of stock for the three months ended in Jun. 2017 was $0.0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

NCI's repurchase of stock for the three months ended in Jun. 2017 was $0.0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

NCI's net issuance of debt for the three months ended in Jun. 2017 was $-2.0 Mil. NCI spent $2.0 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

NCI's net issuance of preferred for the three months ended in Jun. 2017 was $0.0 Mil. NCI paid $0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

NCI's cash flow for dividends for the three months ended in Jun. 2017 was $0.0 Mil. NCI received $0.0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

NCI's other financing for the three months ended in Jun. 2017 was $0.4 Mil. NCI received $0.4 Mil on other financial activities.


NCI Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of NCI's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


NCI (NCIT) Business Description

Industry
Traded in Other Exchanges
N/A
Address
NCI Inc is a Delaware corporation incorporated in July 2005. The Company provides enterprise services and solutions to Defense, Intelligence, Healthcare, and Civilian Government agencies. The Company provides services in areas including cybersecurity and information assurance; engineering and logistics support; enterprise information management and advanced analytics; cloud computing and information technology (IT) infrastructure optimization; health IT and medical support; IT service management; and modeling, simulation and training. The Company uses an integrated, tailorable engineering and operations methodology for governing how it provides cloud computing and IT infrastructure optimization services that fulfill its customer's important mission needs. It supports Department of Defense (DoD) weapon systems lifecycle support efforts in diminishing manufacturing sources and material shortages (DMSMS) analysis and engineering solutions in support of modernization and technology insertion. It supports rapid and relevant discovery, anticipatory intelligence, focused analysis, and persistent surveillance across multiple customer domains and operational disciplines as well as enriches the intelligence-to-operations lifecycle by applying scalable technologies and advanced algorithms to help interpret data. The Company provides a broad spectrum of health IT services experience, including cybersecurity/IA, Health Insurance Portability and Accountability Act (HIPPA) and Federal Information Security Management Act (FISMA) compliance, data analysis/management. The Company designs, installs, and manages complex mission-critical enterprise systems for its customers, increasing the reliability, security, and efficiency of their IT operations while meeting stringent guidelines and requirements. The Company often competes against or team with divisions of Defense and IT services contractors, including Lockheed Martin Corporation, Northrop Grumman Corporation, General Dynamics Corporation, Computer Sciences Corporation, Raytheon, Harris, BAE Systems, Booz Allen Hamilton, Leidos, and Science Applications International Corporation (SAIC). It also competes against or team with mid-tier Federal contractors, such as CACI International and ManTech International that have specialized capabilities, as well as numerous non-public companies within the sector. The Company is subject to various laws and regulations that may affect its business. U.S. Federal Government contracts are subject to a number of Federal laws and regulations, including the Federal Acquisition Regulation (FAR).
Executives
Yerks Austin J. Iii director 9404 LAGOVISTA COURT, GREAT FALLS VA 22066
James P Allen director C/O GRC INTERNATIONAL INC, 1900 GALLOWS RD, VIENNA VA 22182
Philip O Nolan director 15052 CONFERENCE CENTER DRIVE, CHANTILLY VA 20151
Stephen L Waechter director 1100 N GLEBE ROAD, ARLINGTON VA 22201
Judith L Bjornaas officer: Executive VP and CFO 12015 LEE JACKSON MEMORIAL HWY., MANTECH INTERNATIONAL CORPORATION, FAIRFAX VA 22033

NCI (NCIT) Headlines

From GuruFocus

NCI Inc. Reports Operating Results (10-Q)

By gurufocus 05-08-2009

NCI Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 11-04-2010

NCI Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 08-05-2010

NCI Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 11-05-2009

NCI Inc. Reports Operating Results (10-K)

By gurufocus 10qk 02-28-2011

NCI Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 05-06-2010

NCI Inc. Reports Operating Results (10-Q)

By gurufocus 08-06-2009